• Sign In
  • Sign Up
  • Sign In
  • Sign Up
  • Home
  • Cardiology
  • Endocrinology
  • Neurology
  • Nephrology
  • Dermatology
  • Oncology
  • Obstetrics & Gynecology
  • Otolaryngology
  • Home
  • Cardiology
  • Endocrinology
  • Neurology
  • Nephrology
  • Dermatology
  • Oncology
  • Obstetrics & Gynecology
  • Otolaryngology
ADA 85th Scientific Sessions ’25

Time in Range (TIR) Extrapolated from Self- Monitoring of Blood Glucose (SMBG) and Risk for Adverse Perinatal Outcomes in Pregnancies Complicated by T1DM

This paper was presented as a part of the session “New Approaches to Detect and Monitor Diabetes in Pregnancy?” on June 21st, 2025, at the

Read More »
August 5, 2025
ADA 85th Scientific Sessions ’25

Hyperglycemia Threshold Associated with Adverse Pregnancy Outcomes in Gestational Diabetes Mellitus

This paper was presented as a part of the session “New Approaches to Detect and Monitor Diabetes in Pregnancy?” on June 21st, 2025, at the

Read More »
August 1, 2025
ADA 85th Scientific Sessions ’25

Machine Learning Reveals CGM Superiority over Hypoglycemia Awareness Questionnaires in Discriminating Individuals with Severe Hypoglycemia

This paper was presented as a part of the session “Clinical Applications of Artificial Intelligence and Diabetes Technology” on June 21st, 2025, at the 85th

Read More »
July 31, 2025
ADA 85th Scientific Sessions ’25

Carbohydrate Eating—Timing, Gut Microbiome, and Cardiometabolic Disease

This paper was presented as a part of the session “Understanding Diabetes Risk—Are You What You Eat?” on June 21st, 2025, at the 85th ADA

Read More »
July 29, 2025
ADA 85th Scientific Sessions ’25

Changes in Barriers to Physical Activity in Adults with Type 1 Diabetes—Association with Clinical and Psychological Factors

This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in Chicago, IL by Dr. Jane

Read More »
July 28, 2025
ADA 85th Scientific Sessions ’25

Safety, Tolerability, and Clinical Effects of Dapiglutide, a Once- Weekly GLP-1R/GLP- 2R Agonist

This paper was presented as a part of the session “Incretin-Based Combination Therapies for Obesity—Clinical Studies” on June 20th 2025 at the 85th ADA Scientific

Read More »
July 24, 2025
ADA 85th Scientific Sessions ’25

ADA Releases First- Ever Obesity Care Guidelines, Prioritizing Bias Reduction and Personalized Treatment

The 85th American Diabetes Association Annual Scientific Sessions began on June 20th 2025 in Chicago, Illinois. The first Standards of Care in Overweight and Obesity

Read More »
July 23, 2025
ADA 85th Scientific Sessions ’25

Social Determinants of Physical Activity in Young Adults with and without Prediabetes or Type 2 Diabetes

This paper was presented as a part of the session “Physical Activity—Barriers, Facilitators, and Key Outcomes”on June 20th 2025 at the 85th ADA Scientific Sessions

Read More »
July 22, 2025
ADA 85th Scientific Sessions ’25

Risks of Cancers among Novel Subtypes of Type 2 Diabetes—A Longitudinal Analysis from the United States

This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in Chicago, IL by Zhongyu Li

Read More »
July 21, 2025
ADA 85th Scientific Sessions ’25

Longitudinal Trends in Diabetic Foot Ulcers and Lower Extremity Amputations before and after the COVID-19 Pandemic

This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in Chicago, IL by Ivan Y

Read More »
July 18, 2025
Page1 Page2 Page3 Page4 Page5
Latest Conferences
  • Age-Related Adaptations in Methylglyoxal Detoxification: Insights from Normoglycaemia and Prediabetes
  • Clustering of Continuous Glucose Monitoring Data Reveals Distinct Phenotypes of Insulin Resistance in Individuals with Overweight and Grade 1 Obesity
  • Transforming Inpatient Glycaemic Management: A System-Wide Approach to Reducing Hyperglycaemia and Hypoglycaemia
  • Impact of Overweight and Obesity on Fasting Insulin Secretion in Men and Women without Diabetes: Effect Sizes and Mechanisms
  • Mortality, Kidney, and Safety Outcomes with SGLT-2 Inhibitors vs DPP4 Inhibitors in Patients with Type 2 Diabetes Treated with Systemic Glucocorticoids
Societies
  • ACC: American College of Cardiology
  • ADA: American Diabetes Association
  • ASN: American Society of Nephrology
  • BAD: British Association of Dermatologists
  • ERA EDTA: European Renal Association – European Dialysis and Transplant Association
  • ESC: European Society of Cardiology
  • ISN: International Society of Nephrology
  • WCPD: World Congress of Pediatric Dermatology
  • AHA: American Heart Association
  • AAD: American Association of Dermatology
  • AACE: American Association of Clinical Endocrinology
  • ADA: American Diabetes Association
  • ASN: American Society of Nephrology
  • ISN: International Society of Nephrology
  • IASP: International Association for the Study of Pain
  • SCAI: Society for Cardiovascular Angiography and Interventions
  • AAO-HNS: American Academy of Otolaryngology–Head and Neck Surgery
Speciality
  • Cardiology
  • Endocrinology
  • Nephrology
  • Neurology
  • Dermatology
  • Obstetrics & Gynecology
  • Pain
  • Respiratory
  • Otolaryngology
Tags
AACE ACC ADA AHA ASN BAD ERA ESC ISN ISN-WCN 2021 Kidney Week 2020 SCAI WCPD wcpn

© All rights reserved.